Ethical Considerations During clinical trials, participants are either already on a stable, maintenance dose or are provided with the GLP-1 medication for the studys duration
Once your thyroid function is stable, we can evaluate whether GLP-1 therapy is an appropriate and powerful next step in your journey toward metabolic health, sustainable weight loss, and improved quality of life
Patient autonomy in dosing can provide psychological benefits, as adjusting your dose within a safe range based on symptom severity allows for better comfort and adherence
The overlap in claimed benefitsparticularly glucose controlcreates natural concern about safety
22 Utah Medicaid began a one-year pilot starting July 1, 2025, for the FFS benefit only
Pharmacokinetics and safety of Iglarlixi in healthy chinese participants: Results of a phase 1 randomized study